Ticker brief
CELC CELCUITY INC
Consumer, Non-cyclical · Biotechnology
last close
$88.44
1 day
-5.1%
14 days
-3.9%
mkt cap
$5.3B
signals 14d
5
authors 14d
5
crowd 14d
-1.8σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 54% cheap · 1 pctile own 1y | IV/HV 0.98× (as of 2026-08-25) |
| Skew — 25Δ RR 30d | -0.021 66 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | -1.57 thin | 5-session Δ -2.40 (as of 2026-07-16) |
| OI alarm | in alarm 1d streak | z=4.5 on 2026-07-15 |
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-26 · now +0.20 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Quantumup1 | C | · | 1 | +0.40 |
| @TheNewMoney_app | C | · | 1 | +0.25 |
| @CrweWorld | C | · | 1 | +0.25 |
| @OzmosiHealth | C | · | 1 | +0.25 |
| @BiopharmIQ | B | · | 1 | +0.10 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-26 | @BiopharmIQ | +0.10 | Lists biotech opening moves and associated catalysts across multiple names. | -7.0% | tweet ↗ |
| 2026-08-26 | @OzmosiHealth | +0.25 | Celcuity submitted an sNDA to the FDA for REVTORPYK. | -7.0% | tweet ↗ |
| 2026-08-26 | @CrweWorld | +0.25 | Celcuity submitted a supplemental new drug application to the FDA. | -7.0% | tweet ↗ |
| 2026-08-21 | @TheNewMoney_app | +0.25 | Reports $136,000 of CELC 150 calls purchased for the January 2028 expiry. | -5.4% | tweet ↗ |
| 2026-08-17 | @Quantumup1 | +0.40 | Guggenheim reiterated Buy and raised CELC's target to $175 from $165. | -4.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.